VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
EASL 2026 | Hepatitis B New Drug GSK836 Phase III Data Published: Can It Optimize Hepatitis B Cure Strategies?
EASL 2026 | Hepatitis B New Drug GSK836 Phase III Data Published: Can It Optimize Hepatitis B Cure Strategies?
May 29, 2026 20:00 CST Updated May 30, 02:40
Share:
GSK China
Pharmaceutical Manufacturer